文献速递心外重症与机械循环支持

离体心脏灌注减轻DCD心脏移植长时间无心跳期后的早期风险

Ex-vivo heart perfusion attenuates early post-transplant risk after prolonged agonal period in DCD heart transplantation.
PubMed 文献 · J Heart Lung Transplant · 2025-11-13

基于UNOS数据库2019年1月至2025年4月的1682例DCD心脏移植受体,评估离体心脏灌注(EVHP)对无心跳期(AP)所致风险的缓解作用。多变量Cox模型显示,未使用EVHP且AP≥30分钟者1年死亡率显著升高(HR 2.17),而EVHP组无论AP长短均无超额风险;倾向性评分匹配亚组中EVHP改善1年生存。

要点

  • 未使用EVHP且AP≥30分钟的DCD心脏移植1年死亡率显著增加(HR 2.17)。
  • 使用EVHP者无论AP是否≥30分钟,1年死亡风险均未见显著升高。
  • 静态保存的长时间AP移植物院内急性排斥风险更高(aOR 2.56)。

核心结论

  • EVHP可能减轻美国DCD心脏移植中长时间AP带来的生存和排斥惩罚。
  • 对AP≥30分钟的供者更广泛采用EVHP或可安全扩大DCD心脏池而不损害结局。

研究设计与样本

  • 回顾性队列研究,纳入UNOS胸科登记库2019年1月至2025年4月成人(≥18岁)孤立心脏移植。
  • 共分析1682例DCD受体,其中1175例(69.9%)接受EVHP;AP≥30分钟者359例。
  • 采用多变量Cox和 logistic 模型调整供者、受体、操作及中心因素,并在长时间AP亚组进行倾向性评分匹配。

主要发现

  • 总体1年生存率为90.7%。
  • 完全调整Cox模型中,无EVHP且AP≥30分钟者较参照组(无EVHP且AP<30分钟)1年死亡率更高(HR 2.17;95% CI 1.05-4.47;p=0.037)。
  • EVHP组无超额风险:EVHP+AP<30分钟HR 0.93(95% CI 0.54-1.62;p=0.809);EVHP+AP≥30分钟HR 0.98(95% CI 0.49-1.96;p=0.953)。
  • AP≥30分钟倾向性评分匹配亚组(n=240;120例EVHP,120例无EVHP)中,EVHP改善1年生存(log-rank p=0.03)。
  • 静态保存的长时间AP移植物院内急性排斥几率更高(aOR 2.56;95% CI 1.07-6.14;p=0.04);卒中、透析和起搏器使用无差异。

关键数值与推荐

  • AP≥30分钟定义为长时间无心跳期。
  • 无EVHP且AP≥30分钟者1年死亡HR 2.17(95% CI 1.05-4.47;p=0.037)。
  • 静态保存长时间AP移植物急性排斥aOR 2.56(95% CI 1.07-6.14;p=0.04)。

临床怎么用

  • 对AP≥30分钟的DCD心脏供者,优先考虑使用EVHP以降低1年死亡和急性排斥风险。
  • EVHP可能安全地扩大DCD心脏供者池,尤其适用于长时间AP供者。

局限性

  • 回顾性登记研究,存在未测量混杂可能。
  • EVHP使用非随机分配,尽管进行了多变量调整和倾向性评分匹配。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Warm ischemic injury during the agonal period (AP) threatens graft viability in donation-after-circulatory-death (DCD) heart transplantation. Whether ex vivo heart perfusion (EVHP) mitigates these risks remains unclear. METHODS: Adult (≥18 years) isolated heart transplants reported to the United Network for Organ Sharing (UNOS) thoracic registry (January 2019-April 2025) were reviewed. Recipients lacking AP or perfusion data were excluded. The primary exposure was EVHP, defined as use of an ex vivo perfusion device following donor cardiectomy; static cold storage served as the reference. Multivariable Cox and logistic models adjusted for donor, recipient, procedural, and center-level factors. Propensity score matching was performed in the prolonged AP subgroup. RESULTS: Among 1,682 donation after circulatory death (DCD) recipients, 1,175 (69.9%) received ex vivo heart perfusion (EVHP). Prolonged AP (≥30 min) occurred in 359 cases. One-year survival was 90.7% overall. In the fully adjusted Cox model, no-EVHP grafts with AP ≥30 min had higher 1-year mortality versus the reference (no-EVHP + <30 min) (HR 2.17; 95% CI 1.05-4.47; p = 0.037). EVHP grafts showed no excess risk regardless of AP (EVHP + <30 min: HR 0.93; 95% CI 0.54-1.62; p = 0.809; EVHP + ≥30 min: HR 0.98; 95% CI 0.49-1.96; p = 0.953). Age, creatinine, out-of-body time, and adult congenital heart disease (ACHD) increased mortality; ventricular assist device (VAD) at listing and high-volume centers were protective; sex was not significant. In the AP ≥30-min propensity score matching (PSM) subgroup (n = 240; 120 EVHP, 120 no EVHP), EVHP improved 1-year survival (log-rank p = 0.03). Spline modeling showed rising mortality beginning ∼20 min of AP for static-preserved grafts, with a flat risk curve under EVHP. Static-preserved prolonged-AP grafts had higher odds of acute rejection before discharge (aOR 2.56; 95% CI 1.07-6.14; p = 0.04); stroke, dialysis, and pacemaker use did not differ. CONCLUSIONS: EVHP may mitigate survival and rejection penalties of prolonged AP in the U.S. DCD heart transplantation. Broader EVHP adoption for donors with AP ≥30 min may safely expand the DCD heart pool without compromising outcomes.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Berg AR, Krishnan A, Heng EE, et al. Ex-vivo heart perfusion attenuates early post-transplant risk after prolonged agonal period in DCD heart transplantation. J Heart Lung Transplant. 2025. PMID: 41241031. doi:10.1016/j.healun.2025.10.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。